A role for alpha-synuclein in the regulation of dopamine biosynthesis.

535 indexed citations
published 2002

Countries where authors are citing A role for alpha-synuclein in the regulation of dopamine biosynthesis.

Specialization
Citations

This map shows the geographic impact of A role for alpha-synuclein in the regulation of dopamine biosynthesis.. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A role for alpha-synuclein in the regulation of dopamine biosynthesis. with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A role for alpha-synuclein in the regulation of dopamine biosynthesis. more than expected).

Fields of papers citing A role for alpha-synuclein in the regulation of dopamine biosynthesis.

Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of A role for alpha-synuclein in the regulation of dopamine biosynthesis.. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the A role for alpha-synuclein in the regulation of dopamine biosynthesis..

About A role for alpha-synuclein in the regulation of dopamine biosynthesis.

This paper, published in 2002, received 535 indexed citations . Written by Ruth G. Perez, Jack C. Waymire, Eva Lin, Fengli Guo and Michael J. Zigmond covering the research area of Neurology and Cellular and Molecular Neuroscience. It is primarily cited by scholars working on Neurology (418 citations), Cellular and Molecular Neuroscience (295 citations) and Physiology (142 citations). Published in PubMed.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

This paper is also available at doi.org/w23984717.

Explore hit-papers with similar magnitude of impact

Breakdown of academic impact, for the paper Electroencephalogram signatures of loss and recovery of consciousness from propofolBreakdown of academic impact, for the paper Primary Tumor Response to Preoperative Chemoradiation With or Without Oxaliplatin in Locally Advanced Rectal Cancer: Pathologic Results of the STAR-01 Randomized Phase III TrialBreakdown of academic impact, for the paper Phase II Trial of Sorafenib in Advanced Thyroid CancerBreakdown of academic impact, for the paper Genome-wide analysis of mRNA translation profiles in Saccharomyces cerevisiaeBreakdown of academic impact, for the paper Gut microbiota induce IGF-1 and promote bone formation and growthBreakdown of academic impact, for the paper Clinical Features of 8295 Patients With Resistant Hypertension Classified on the Basis of Ambulatory Blood Pressure MonitoringBreakdown of academic impact, for the paper RNA Polymerase IV Directs Silencing of Endogenous DNABreakdown of academic impact, for the paper Offspring from Oocytes Derived from in Vitro Primordial Germ Cell–like Cells in MiceBreakdown of academic impact, for the paper Pazopanib, a Multikinase Angiogenesis Inhibitor, in Patients With Relapsed or Refractory Advanced Soft Tissue Sarcoma: A Phase II Study From the European Organisation for Research and Treatment of Cancer–Soft Tissue and Bone Sarcoma Group (EORTC Study 62043)Breakdown of academic impact, for the paper Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder
Rankless by CCL
2026